10. Unprecedented Results: Nearly 100% Reduction

A single high-dose injection of lepodisiran produced a stunning outcome—participants’ Lp(a) levels dropped by nearly 100% at six months. With a second dose, this dramatic effect was maintained for a full year, marking the most significant reduction ever observed in Lp(a) therapy. These results set a new benchmark for genetic cholesterol treatment. For more on these findings, see Fox News coverage.